Intrauterine antibiotic exposure affected neonatal gut bacteria and infant growth speed

Yuhan Zhou1, Wenjuan Ma2, Yu Zeng3

  • 1Key Lab of Health Technology Assessment, National Health Commission of the People's Republic of China, Fudan University, Shanghai, 200032, China; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, 200032, China.

Insights

Intrauterine antibiotic exposure, particularly penicillin, impacts infant growth and growth speed. Neonatal gut microbiota may mediate this association, affecting weight and BMI development.

Area of Science:

  • Microbiology
  • Pediatrics
  • Environmental Health

Background:

  • Early-life antibiotic exposure is linked to later adipogenesis.
  • Limited data exist on intrauterine antibiotic exposure's effect on infant growth and growth speed.
  • The role of neonatal gut microbiota in this association is understudied.

Purpose of the Study:

  • To examine the association between intrauterine cumulative antibiotic exposure and infant growth.
  • To explore the potential role of the neonatal gut microbiota in mediating this association.

Main Methods:

  • Study included 295 mother-child pairs from the Shanghai Maternal-Child Pairs Cohort (MCPC).
  • Meconium samples and infant growth measurements (length-for-age, weight-for-age, BMI-for-age Z-scores) were assessed.
  • Eighteen common antibiotics were measured in meconium; multivariable linear regression and LASSO were used.

Main Results:

  • Penicillin exposure was positively associated with infant growth at birth and growth speed from 2 to 6 months.
  • Gut microbiota diversity indexes (Pielou, Simpson) were negatively associated with penicillin and infant growth.
  • Specific bacterial taxa abundances (Actinobacteria, Firmicutes, Bifidobacteriales) correlated with infant weight and BMI growth speeds.

Conclusions:

  • Intrauterine antibiotic exposure significantly affects infant growth.
  • The neonatal gut microbiota may play a crucial role in mediating the effects of intrauterine antibiotic exposure on infant growth.

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
84.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
39
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
630
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
47